Skip to main content
. 2022 Mar 9;13:847387. doi: 10.3389/fphar.2022.847387

TABLE 1.

Development of antibodies against DKK1.

Antibodies Model(s) Disease(s) References
BHQ880 5T2MM murine model of myeloma MM Heath et al. (2009)
SCID-hu mouse model of human myeloma MM Fulciniti et al. (2009)
Orthotopic patient-derived xenograft model of osteosarcoma Osteosarcoma Goldstein et al. (2016)
DKN-01 Patients with relapsed/refractory esophagogastric cancer Esophagogastric cancer Wall et al. (2020)
Patients with biliary tract cancer Biliary tract cancer Goyal et al. (2020)
C57BL/6 mice Ovarian cancer Betella et al. (2019)
ID8 syngeneic mice Epithelial ovarian cancer Betella et al. (2020)
Patients with MM or advanced solid tumors MM or advanced solid tumors Ryan et al. (2016)
Gynecologic malignancy patients Gynecologic malignancies Arend et al. (2019a)
NSCLC patients NSCLC Edenfield et al. (2014)
RH2-18 Ovariectomized C57BL/6NTac mice and rhesus macaques Postmenopausal osteoporosis Glantschnig et al. (2011)
Hetero-DS Femur fracture model in rats Fracture Florio et al. (2016)
Cynomolgus monkey Postmenopausal osteoporosis Florio et al. (2016)